Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Theravance Biopharma R&D IP, LLC”

252 pharma patents match "Theravance Biopharma R&D IP, LLC" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 252
Index total 30,257
Page 7 / 11

Quick answer

This filtered view shows 252 pharmaceutical patents matching "Theravance Biopharma R&D IP, LLC" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

252 results for “Theravance Biopharma R&D IP, LLC” · 30,257 patents in full index Clear search

  1. US 9845332

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Dec 19, 2017 · Expires Dec 14, 2037

    granted
  2. US 9840460

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Dec 12, 2017 · Expires Dec 7, 2037

    granted
  3. US 9839639

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Dec 12, 2017 · Expires Dec 7, 2037

    granted
  4. US 9828367

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Nov 28, 2017 · Expires Nov 23, 2037

    granted
  5. US 9783507

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted
  6. US 9771337

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Sep 26, 2017 · Expires Sep 21, 2037

    granted
  7. US 9765028

    Crystalline freebase forms of a biphenyl compound

    Theravance Biopharma R&D IP, LLC · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted
  8. US 9725448

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Aug 8, 2017 · Expires Aug 3, 2037

    granted
  9. US 9725470

    Substituted naphthyridines as JAK kinase inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Aug 8, 2017 · Expires Aug 3, 2037

    granted
  10. US 9724359

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Aug 8, 2017 · Expires Aug 3, 2037

    granted
  11. US 9688616

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Jun 27, 2017 · Expires Jun 22, 2037

    granted
  12. US 9688692

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Jun 27, 2017 · Expires Jun 22, 2037

    granted
  13. US 9682052

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Jun 20, 2017 · Expires Jun 15, 2037

    granted
  14. US 9683002

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Jun 20, 2017 · Expires Jun 15, 2037

    granted
  15. US 9675599

    4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds

    Theravance Biopharma R&D IP, LLC · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted
  16. US 9670186

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted
  17. US 9670140

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted
  18. US 9669027

    Hepatitis C virus inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted
  19. US 9670143

    (2S,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydroxmethyl-2-methylpentanoic acid

    Theravance Biopharma R&D IP, LLC · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted
  20. US 9663509

    8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

    Theravance Biopharma R&D IP, LLC · Granted May 30, 2017 · Expires May 25, 2037

    granted
  21. US 9656993

    Crystalline forms of a biphenyl compound

    Theravance Biopharma R&D IP, LLC · Granted May 23, 2017 · Expires May 18, 2037

    granted
  22. US 9630960

    Quinolinone-carboxamide compounds as 5-HT4 receptor agonists

    Theravance Biopharma R&D IP, LLC · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted
  23. US 9593110

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted
  24. US 9585882

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Mar 7, 2017 · Expires Mar 2, 2037

    granted